Cargando…

Clinical and laboratory markers associated with anti-TNF-alpha trough levels and anti-drug antibodies in patients with inflammatory bowel diseases

Monitoring anti-TNF agents in inflammatory bowel disease (IBD) patients may be helpful in optimizing outcomes. We aimed to evaluate potential correlations among demographic, clinical, laboratory, or imaging parameters, as well as serum levels of infliximab (IFX) and adalimumab (ADA) and their respec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grinman, Ana B., de Souza, Maria das Graças C., Bouskela, Eliete, Carvalho, Ana Teresa P., de Souza, Heitor S. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478556/ https://www.ncbi.nlm.nih.gov/pubmed/32150077 http://dx.doi.org/10.1097/MD.0000000000019359

Ejemplares similares

Mechanisms of action of molecules with anti-TNF-alpha activity on intestinal barrier inflammation: A systematic review protocol
por: Lima, Mayara Santa Rosa, et al.
Publicado: (2019)

Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review
por: de Aragão, Maria Cecília, et al.
Publicado: (2021)

The safety of vedolizumab in a patient with Crohn’s disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report
por: Sugiyama, Yuya, et al.
Publicado: (2023)

Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
por: Malvão, Ludimilla dos Reis, et al.
Publicado: (2021)

Tuberculoid leprosy: An in vivo microvascular evaluation of cutaneous lesions
por: Pino, Livia, et al.
Publicado: (2020)

The effect of early trough level of infliximab on subsequent disease course in patients with Crohn disease: A prospective cohort study
por: Ishida, Natsuki, et al.
Publicado: (2020)

Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study
por: Sakai, Masahiro, et al.
Publicado: (2023)

Evaluation of ustekinumab trough levels during induction and maintenance therapy with regard to disease activity status in difficult to treat Crohn disease patients
por: Mechie, Nicolae-Catalin, et al.
Publicado: (2021)

Microvascular Function, Inflammatory Status, and Oxidative Stress in Post-Bariatric Patients with Weight Regain
por: Lopes, Karynne Grutter, et al.
Publicado: (2023)

Association between bowel habits and quality of bowel preparation for colonoscopy
por: Lee, Dong-won, et al.
Publicado: (2017)

Anti-TNF-alpha-induced lupus
por: De Bandt, Michel
Publicado: (2019)

Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma
por: Schraiber, Luciana dos Santos, et al.
Publicado: (2016)

Pneumococcal Vaccination Rates in VHA Patients With Inflammatory Bowel Disease
por: Case, David J., et al.
Publicado: (2015)

n-3 PUFA Induce Microvascular Protective Changes During Ischemia/Reperfusion
por: Souza, Maria das Graças Coelho de, et al.
Publicado: (2014)

Small bowel capsule endoscopy revealing neuromuscular and vascular hamartoma of the jejunum: A case report
por: Caruso, Maria L., et al.
Publicado: (2018)

Thalidomide for inflammatory bowel disease: Systematic review
por: Bramuzzo, Matteo, et al.
Publicado: (2016)

Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody
por: Lai, Ming-Wei, et al.
Publicado: (2016)

Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients
por: Álvarez-López, Patricia, et al.
Publicado: (2020)

Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease
por: Martinez-Fierro, Margarita L., et al.
Publicado: (2019)

Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease
por: Steenholdt, Casper, et al.
Publicado: (2016)

Pulmonary dysfunction in 114 patients with inflammatory bowel disease
por: Zhao, Yujie, et al.
Publicado: (2017)

Cardiac events after using clarithromycin for anti-Helicobacter pylori therapy in patients with coronary artery disease
por: Lin, Cheng-Kuan, et al.
Publicado: (2023)

Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life
por: Ozer, Muhammet, et al.
Publicado: (2020)

The features and clinical outcomes of inflammatory bowel disease associated with autoimmune pancreatitis: A greater awareness is needed
por: Conti Bellocchi, Maria Cristina, et al.
Publicado: (2022)

Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel disease
por: Huoponen, Saara, et al.
Publicado: (2020)

Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis
por: Chang, Yue, et al.
Publicado: (2020)

Efficacy of complementary medicine for nonsteroidal anti-inflammatory drug-induced small intestinal injuries: A narrative review
por: Cho, Minji, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

Physical activity and quality of life of patients with inflammatory bowel disease
por: Kim, Bun, et al.
Publicado: (2021)

What are the risk factors for extraintestinal manifestations in inflammatory bowel diseases?
por: Yeo, Min-Kyung, et al.
Publicado: (2023)

Education for Ward Nurses Influences the Quality of Inpatient's Bowel Preparation for Colonoscopy
por: Lee, Yoo Jin, et al.
Publicado: (2015)

Preventative care for patients with inflammatory bowel disease in the Veterans Health Administration
por: Pandey, Nivedita, et al.
Publicado: (2016)

Fatty acid components in Asian female patients with irritable bowel syndrome
por: Chua, Chian Sem, et al.
Publicado: (2017)

Bacillus coagulans (PROBACI) in treating constipation-dominant functional bowel disorders
por: Chang, Chen-Wang, et al.
Publicado: (2020)

Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2022)

Buspirone in the management of refractory irritable bowel syndrome: A case report
por: Karim, Mustafa Abdul, et al.
Publicado: (2021)

Lower vitamin D levels are associated with the pathogenesis of inflammatory bowel diseases
por: Topalova-Dimitrova, Antonia, et al.
Publicado: (2023)

Dipeptidyl Peptidase 4 Activity Is Related to Body Composition, Measures of Adiposity, and Insulin Resistance in Subjects with Excessive Adiposity and Different Degrees of Glucose Tolerance
por: Silva Júnior, Wellington S., et al.
Publicado: (2019)

H3K9 acetylation modification and TLR9 immune regulation mechanism in patients after anti-HBV treatment
por: Zhu, Haipeng, et al.
Publicado: (2022)

A rare case report of iatrogenic Cushing syndrome caused by direct anti-hepatitis C virus therapy with sofosbuvir/velpatasvir
por: Ma, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sr40i30qt6t8hr316anbv66upe